Yasuko Aoki

756 total citations
36 papers, 434 citations indexed

About

Yasuko Aoki is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Yasuko Aoki has authored 36 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Yasuko Aoki's work include Antimicrobial Resistance in Staphylococcus (6 papers), Mycobacterium research and diagnosis (4 papers) and Streptococcal Infections and Treatments (3 papers). Yasuko Aoki is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Mycobacterium research and diagnosis (4 papers) and Streptococcal Infections and Treatments (3 papers). Yasuko Aoki collaborates with scholars based in Japan, United States and Tunisia. Yasuko Aoki's co-authors include Satoshi Iwata, Eiichi Nakayama, Takeshi Tajima, Reiko Kobayashi, Keiko Hasegawa, Naoko Chiba, Kimiko Ubukata, Miyuki Morozumi, Masami Nakajima and Masaya Igarashi and has published in prestigious journals such as Kidney International, Journal of Clinical Microbiology and Experimental Cell Research.

In The Last Decade

Yasuko Aoki

34 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuko Aoki Japan 10 141 134 74 58 57 36 434
Fang‐Yeh Chu Taiwan 13 167 1.2× 108 0.8× 31 0.4× 45 0.8× 76 1.3× 39 446
Marine Meunier France 13 113 0.8× 129 1.0× 99 1.3× 77 1.3× 90 1.6× 24 717
C. L. Jones Australia 11 77 0.5× 54 0.4× 73 1.0× 43 0.7× 128 2.2× 20 401
Ute Rohr Germany 10 64 0.5× 136 1.0× 19 0.3× 31 0.5× 147 2.6× 15 498
Cemalettin Aybay Türkiye 14 124 0.9× 51 0.4× 19 0.3× 34 0.6× 76 1.3× 36 486
R. M. L. Mehrotra India 14 103 0.7× 87 0.6× 31 0.4× 43 0.7× 45 0.8× 46 493
J. Verhoef Netherlands 8 114 0.8× 111 0.8× 34 0.5× 34 0.6× 79 1.4× 15 391
Kazuo Tobe Japan 12 253 1.8× 34 0.3× 58 0.8× 18 0.3× 125 2.2× 35 709
S Bala United States 8 274 1.9× 63 0.5× 71 1.0× 26 0.4× 61 1.1× 12 758
B U Ridwan Netherlands 10 133 0.9× 70 0.5× 33 0.4× 93 1.6× 71 1.2× 12 518

Countries citing papers authored by Yasuko Aoki

Since Specialization
Citations

This map shows the geographic impact of Yasuko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Aoki more than expected).

Fields of papers citing papers by Yasuko Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Aoki. The network helps show where Yasuko Aoki may publish in the future.

Co-authorship network of co-authors of Yasuko Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Aoki. A scholar is included among the top collaborators of Yasuko Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Aoki. Yasuko Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Môri, N., et al.. (2019). Clinical and molecular analyses of bloodstream infections caused by IMP metallo-β-lactamase-producing Enterobacteriaceae in a tertiary hospital in Japan. Journal of Infection and Chemotherapy. 26(1). 144–147. 11 indexed citations
2.
Môri, N., et al.. (2017). Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case–control studies of incidence and associated risk factors. European Journal of Clinical Pharmacology. 74(4). 405–411. 9 indexed citations
3.
Môri, N., et al.. (2017). Peripherally inserted central catheter-related bloodstream infection caused by Kocuria marina in an elderly man. Infection. 45(5). 683–686. 6 indexed citations
4.
Môri, N., Yoshitaka Oyamada, Yasuhiro Yamada, et al.. (2016). Characteristics of mucoid Streptococcus pyogenes isolated from two patients with pneumonia in a local community. IDCases. 6. 43–46. 5 indexed citations
5.
7.
Aoki, Yasuko, et al.. (2012). Ocular Hypotensive Effect and Safety of Travoprost 0.004% Timolol Maleate 0.5% Fixed Combination, Switched from Travoprost 0.004% Alone for 3 Months. 29(11). 1559–1562. 1 indexed citations
8.
Bito, Seiji, et al.. (2011). Association between the number of blood cultures and appropriateness of care for suspected bacteremic urinary tract infection in the elderly. Journal of Infection and Chemotherapy. 17(3). 341–350. 2 indexed citations
9.
Morozumi, Miyuki, Eiichi Nakayama, Satoshi Iwata, et al.. (2006). Simultaneous Detection of Pathogens in Clinical Samples from Patients with Community-Acquired Pneumonia by Real-Time PCR with Pathogen-Specific Molecular Beacon Probes. Journal of Clinical Microbiology. 44(4). 1440–1446. 87 indexed citations
11.
Aoki, Yasuko, et al.. (2003). Targeted Bacteremia Surveillance Throughout a Year. Kansenshogaku zasshi. 77(4). 211–218. 2 indexed citations
12.
Zhou, Jianhui, et al.. (2003). H1 genotype of measles virus was detected in outbreaks in Japan after 2000. Journal of Medical Virology. 70(4). 642–648. 25 indexed citations
13.
Taneike, Ikue, Saori Nakagawa, Kyoko Ozaki, et al.. (2002). DNA analysis of nosocomial infection by Enterobacter aerogenes in three cases of septicaemia in Japan. Journal of Hospital Infection. 51(3). 221–225. 2 indexed citations
14.
Kurata, Hirofumi, et al.. (2002). Circulating CD34+ cells to predict the adequate harvest of peripheral blood progenitor cells in platinum-based chemotherapy. Archives of Gynecology and Obstetrics. 266(1). 34–37. 1 indexed citations
15.
Kôyama, Akio, Masaki Kobayashi, Naoto Yamaguchi, et al.. (1995). Glomerulonephritis associated with MRSA infection: A possible role of bacterial superantigen. Kidney International. 47(1). 207–216. 123 indexed citations
16.
Aoki, Yasuko. (1994). Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.. PubMed. 47(6). 640–6. 14 indexed citations
17.
Aoki, Yasuko. (1992). Bactericidal activity of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA)-Comparison with Minomycin and ofloxacin within therapeutic levels, and factors determing their efficacy-. Chemotherapy. 40. 997–1104. 5 indexed citations
18.
Aoki, Yasuko, et al.. (1990). Significance of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus (MRSA) by Medical Staff in Nosocomial Infection. Kansenshogaku zasshi. 64(5). 549–556. 7 indexed citations
19.
Miyazaki, Shuichi, et al.. (1987). Study of the Pathogenecity of Enterococcus faecalis. Kansenshogaku zasshi. 61(3). 318–324. 1 indexed citations
20.
Hanada, Takashi, Yasuko Aoki, Haruhiko Ninomiya, & Tsukasa Abe. (1986). T cell‐mediated inhibition of haematopoiesis in aplastic anaemia: serial assay of inhibitory activities of T cells to autologous CFU‐E during immunosuppressive therapy. British Journal of Haematology. 63(1). 69–74. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026